Diabetes Clinical Trials in Arizona

Showing 301-320 of 565 trials

Molecular Regulation of Muscle Glucose Metabolism

NCT01581736

This protocol is being conducted to determine the mechanisms responsible for insulin resistance, obesity and type 2 diabetes.

ObesityType 2 Diabetes Mellitus

Mayo Clinic48 participantsStarted Apr 2012

Scottsdale, Arizona, United States

COMPLETEDPhase 231 miles

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

NCT00500331

This is a dose-ranging study that will evaluate the efficacy, safety and tolerability of a range of doses of investigational product and pioglitazone, compared to placebo, administered as monotherapy over 12 weeks in treatment naive patients with T2DM

Diabetes Mellitus, Type 2

GlaxoSmithKline334 participantsStarted Jan 2007

Mesa, Arizona, United States • Hollywood, Florida, United States • Miami, Florida, United States +133 more locations

PreviousPage 16 of 29Next

Molecular Regulation of Muscle Glucose Metabolism

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Diabetes Trials in Other Cities

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Extended Follow-Up After Islet Transplantation in T1D

Other Conditions in Arizona